Department of Paediatric Surgery, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
National Perinatal Epidemiology Unit, University of Oxford, Oxford, UK.
Arch Dis Child Fetal Neonatal Ed. 2019 Nov;104(6):F643-F647. doi: 10.1136/archdischild-2018-316396. Epub 2019 Jun 1.
To report outcomes to 1 year, in infants born with congenital diaphragmatic hernia (CDH), explore factors associated with infant mortality and examine the relationship between surgical techniques and postoperative morbidity.
Prospective national population cohort study.
Paediatric surgical centres in the UK and Ireland.
Data were collected to 1 year for infants with CDH live-born between 1 April 2009 to 30 September 2010. Factors associated with infant mortality are explored using logistic regression. Postoperative morbidity following patch versus primary closure, minimally invasive versus open surgery and biological versus synthetic patch material is described. Data are presented as n (%) and median (IQR).
Overall known survival to 1 year was 75%, 95% CI 68% to 81% (138/184) and postoperative survival 93%, 95% CI 88% to 97% (138/148). Female sex, antenatal diagnosis, use of vasodilators or inotropes, being small for gestational age, patch repair and use of surfactant were all associated with infant death. Infants undergoing patch repair had a high incidence of postoperative chylothorax (11/54 vs 2/96 in infants undergoing primary closure) and a long length of hospital stay (41 days, IQR 24-68 vs 16 days, IQR 10-25 in primary closure group). Infants managed with synthetic patch material had a high incidence of chylothorax (11/34 vs 0/19 with biological patch).
The majority of infant deaths in babies born with CDH occur before surgical correction. Female sex, being born small for gestational age, surfactant use, patch repair and receipt of cardiovascular support were associated with a higher risk of death. The optimum surgical approach, timing of operation and choice of patch material to achieve lowest morbidity warrants further evaluation.
报告先天性膈疝(CDH)患儿 1 年的结局,探讨与婴儿死亡率相关的因素,并研究手术技术与术后发病率之间的关系。
全国前瞻性人群队列研究。
英国和爱尔兰的儿科外科中心。
对 2009 年 4 月 1 日至 2010 年 9 月 30 日期间活产的先天性膈疝患儿进行了 1 年的数据收集。使用逻辑回归法探讨了与婴儿死亡率相关的因素。描述了补片修补与直接缝合、微创与开放手术以及生物补片与合成补片之间的术后发病率。数据以 n(%)和中位数(IQR)表示。
总体而言,1 年时已知的生存率为 75%(138/184),95%CI 为 68%至 81%;术后生存率为 93%(138/148),95%CI 为 88%至 97%。女性、产前诊断、使用血管扩张剂或正性肌力药、小于胎龄儿、使用补片修补以及使用表面活性剂与婴儿死亡有关。行补片修补的患儿术后乳糜胸发生率高(11/54 与直接缝合组的 2/96),住院时间长(41 天,IQR 24-68 与直接缝合组的 16 天,IQR 10-25)。使用合成补片材料的患儿乳糜胸发生率高(11/34 与生物补片组的 0/19)。
大多数 CDH 患儿的死亡发生在手术矫正之前。女性、小于胎龄儿、表面活性剂使用、补片修补和心血管支持治疗与死亡风险增加相关。实现最低发病率的最佳手术方法、手术时机和补片材料的选择尚需进一步评估。